FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187 and H.R. 5651

FDA user fees and the regulation of drugs, biologics, and devices : comparative analysis of S. 3187 and H.R. 5651 / Susan Thaul [and six others].

Author/creator	Thaul, Susan author.
Other author/creator	Library of Congress. Congressional Research Service, issuing body.
Format	Electronic and Book
Edition	[Library of Congress public edition].
Publication Info	[Washington, D.C.] : Congressional Research Service, 2018-
Description	1 online resource.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo130961
Subject(s)	United States. Food and Drug Administration--Rules and practice. United States. Food and Drug Administration Safety and Innovation Act. Medical instruments and apparatus industry--Law and legislation --United States. Drugs--Prices --Law and legislation --United States. Medical instruments and apparatus--United States --Costs. User charges--Government policy --United States.

Variant title	Food and Drug Administration user fees and the regulation of drugs, biologics, and devices
Variant title	Comparative analysis of S. 3187 and H.R. 5651
Frequency	Updated irregularly
Series	Report / Congressional Research Service ; R42564 CRS report ; R42564. ^A1365572
General note	The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2012.
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Report includes bibliographical references.
Source of description	Description based on contents viewed on Jan. 21, 2020; title from CRS report home page.
In	Contained in (work): CRS reports (Library of Congress. Congressional Research Service)
LCCN	2020230750
GPO item number	0807-A-07 (online)
Govt. docs number	LC 14.23:R 42564/

Library	Location	Call Number	Status	Item Actions
Joyner	Electronic Resources	Access Content Online	✔ Available